Differential inhibition of the human cell DNA replication complex-associated DNA polymerases by the antimetabolite 1-β- d-arabinofuranosylcytosine triphosphate (ara-CTP)

The antimetabolite 1-β- d-arabinofuranosylcytosine (ara-C) has been used as a highly effective agent for the treatment of leukemia. The active metabolite 1-β- d-arabinofuranosylcytosine triphosphate (ara-CTP) is a potent inhibitor of DNA polymerases α, δ, and ϵ, and is responsible for inhibiting int...

Full description

Saved in:
Bibliographic Details
Published inBiochemical pharmacology Vol. 60; no. 3; pp. 403 - 411
Main Authors Han, Suhua, Hickey, Robert J, Tom, Timothy D, Wills, Philip W, Syväoja, Juhani E, Malkas, Linda H
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.08.2000
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The antimetabolite 1-β- d-arabinofuranosylcytosine (ara-C) has been used as a highly effective agent for the treatment of leukemia. The active metabolite 1-β- d-arabinofuranosylcytosine triphosphate (ara-CTP) is a potent inhibitor of DNA polymerases α, δ, and ϵ, and is responsible for inhibiting intact cell DNA synthesis. We have shown that a multiprotein complex, exhibiting many of the properties expected of the human cell DNA replication apparatus, can be readily isolated from human cells and tissues and is capable of supporting origin-dependent DNA synthesis in vitro. DNA polymerases α, δ, and ϵ are components of this multiprotein complex, termed the DNA synthesome, and we report here that the activities of these DNA synthesome-associated DNA polymerases are inhibited differentially by ara-CTP. Inhibition of the DNA synthesome-associated DNA polymerase α increased in a concentration-dependent manner, and was correlated closely with the inhibition of simian virus 40 (SV40) origin-dependent in vitro DNA replication, whereas DNA synthesome-associated DNA polymerase δ activity was not inhibited significantly by ara-CTP at 100 μM. Recent work has shown that the synthesome-associated DNA polymerase ϵ does not function in in vitro SV40 DNA replication, suggesting that only polymerases α and δ drive the DNA replication fork. Therefore, our results suggest that inhibition of the activity of the mammalian cell DNA synthesome by ara-CTP is due primarily to the inhibition of the DNA synthesome-associated DNA polymerase α. This observation implies that the drug may target specific phases of the DNA synthetic process in human cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-2952
1873-2968
DOI:10.1016/S0006-2952(00)00336-1